In the QIV vs TIV groups and full-dose QIV vs half-dose QIV groups, we evaluated the immunogenicity of A/H1N1, A/H3N2, B/Victoria, and B/Yamagata based on the seroconversion …

2020年1月1日 · The quadrivalent influenza vaccine (QIV) contains two influenza B antigens (one of each B lineage), while the trivalent vaccine (TIV) contains solely one. As a result, a …

2023年3月25日 · 对细胞衍生四价流感疫苗（qivc）与标准鸡胚四价流感疫苗（qiv）在4～64岁人群中的相对疫苗有效性进行分析，结果表明qivc在减少流感样疾病和流感相关住院方面较qiv更 …

2019年10月8日 · 以MDCK细胞系制备的四价灭活流感疫苗已获得欧盟（Flucelvax®Tetra）和美国（FlucelvaxQuadrivalent®，以下简称QIVc）的批准用于预防成人和儿童流感。 QIVc的临床 …

2025年1月24日 · 这是一项随机，盲人，主动控制的III期临床试验，可评估受试者（3岁及以上年龄）对受试者中四价流感病毒分裂疫苗（QIV）的免疫原性和安全性。 原发性免疫原性终点是几 …

Our findings suggest that the QIV provides a superior immunogenicity response compared to the TIV in all age groups evaluated, especially when a lineage mismatch occurred. The safety of …

2022年11月1日 · Safety and immunogenicity of a cell-based quadrivalent inactivated influenza vaccine (QIVc) was compared with a US-licensed vaccine (QIV) in children aged 6 through 47 …

2013年1月21日 · QIV, containing two B strains (one from each B lineage), was as safe and immunogenic as licensed TIV. QIV has the potential to be a useful alternative to TIV and offer …

2020年7月2日 · QIV was found non-inferior to TIVs for shared strains (A/H1N1 and A/H3N2) and corresponding BY strain based on hemagglutination inhibition (HI) antibodies 28 days after the …

2021年10月3日 · Objective: The aim of the current study was to evaluate immunogenicity and safety levels of human inactivated quadrivalent influenza vaccine (QIV) which includes two A …